DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Siguazodan
Siguazodan
Effects of Phosphodiesterase Inhibitors on Human Lung Mast Cell and Basophil Function
(12)发明专利
Phosphodiesterase (PDE)
Rolipram, but Not Siguazodan Or Zaprinast, Inhibits the Excitatory Noncholinergic Neurotransmission in Guinea-Pig Bronchi
Effects of Various Selective Phosphodiesterase Inhibitors on Relaxation and Cyclic Nucleotide Contents in Porcine Iris Sphincter
General Pharmacology
Pharmaceutical Appendix to the Tariff Schedule 2
Selective Phosphodiesterase 4 Inhibitors
Nivedita Singh
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Modulation of Th1/Th2 Cytokine Production by Selective And
Phosphodiesterases As Therapeutic Targets for Respiratory Diseases
Stembook 2018.Pdf
The Effect of Phosphodiesterase Inhibitors on the Induction of Gene Expression by Long-Acting Beta2-Adrenoceptor Agonists and Glucocorticoids
Large-Scale Transcriptional Profiling of Molecular Perturbations Reveals
Mathematical Modeling of Cellular Signal
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
WO 2014/055801 Al 10 April 2014 (10.04.2014) P O P C T
Top View
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Discovery of Novel Molecular and Biochemical Predictors of Response and Outcome in Diffuse Large B-Cell Lymphoma Last, Kim William
Mitigation of NADPH Oxidase 2 Activity As a Strategy to Inhibit Peroxynitrite Formation
(PDE) Isoenzymes As Pharmacologic Targets in Urology: Present and Future
Pharmacology and Toxicology
WO 2018/055211 Al 29 March 2018 (29.03.2018) W !P O PCT
Pharmaabkommen A1 E
New Drugs Review Thorax: First Published As 10.1136/Thx.46.7.512 on 1 July 1991
Customs Tariff - Schedule Xxi - 1
Tarif Intégré Des Communautés Européennes (TARIC)
(51) International Patent Classification: (74) Agent: HARRIS, Bob Et Al.; Viksnins Flarris Padys Malen A61K 31/4725 (2006.01) A6
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
WO 2013/106547 Al 18 July 2013 (18.07.2013) P O P C T
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Comparative Relaxant Effects of Ataciguat and Zaprinast on Sheep Sphincter of Oddi
Cgmp Signaling, Phosphodiesterases and Major Depressive Disorder
Cyclic-AMP-Dependent Proliferation of a Human Osteoblast Cell Line
Harmonized Tariff Schedule of the United States (2006) (Rev
Selective Phosphodiesterase Inhibitors for the Treatment of Bronchial Asthma and Chronic Obstructive Pulmonary Disease
(12) United States Patent (10) Patent No.: US 7,985,756 B2 Barlow Et Al
Pharmacological Potential of PDE5 Inhibitors for the Treatment of Cystic Fibrosis
Role of Phosphodiesterase in the Biology and Pathology of Diabetes
An In-Vitro Model to Predict Cardiac Effects of Drugs
Schedule Clxxiii - European Union
(12) Patent Application Publication (10) Pub. No.: US 2010/0022563 A1 Henkin (43) Pub